DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST).
Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.
J Clin Oncol 2010;
28: 1247-1253
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.